What Is Exosome Therapy? Hair and Lekure Riperteritje Udhezues 2026

Exosome therapy entered aesthetics as a regenerative support tool, not as a miracle replacement for diagnosis. It is discussed most often in two areas: hair restoration and lekure-quality improvement.

The trajtim aims to deliver cell-signaling particles rather than bulk volume. That is why it is often compared with PRP, mesotherapy, or microneedling-based protocols rather than with surgery or traditional mbushess.

1. What exosome therapy is trying to do

Exosomes are extracellular vesicles that carry signaling molecules. In aesthetic practice, the goal is to support tissue repair, inflammatory balance, and regenerative messaging around hair follicles or aging lekure.

This makes the trajtim conceptually attractive for early hair thinning, stressed scalp environments, healing support, and selected lekure-riperteritje plans where collagen quality and repair response matter.

• works as a signaling-based regenerative support
• most useful when tissue is still biologically responsive
• not a substitute for diagnosis or for treating the root cause

2. Exosomes vs PRP vs mesotherapy

PRP uses the patient’s own growth-factor-rich plasma, while mesotherapy usually delivers vitamins, peptides, amino acids, or hydration cocktails. Exosome therapy sits in a different category because it is presented as a biologic signaling product rather than a nutrient or volume trajtim.

In hair care, I often see the best logic in combination planning instead of choosing a single fashionable modality. A patient with androgenetic renia e flokeve may still need topical or oral medical trajtim, scalp care, PRP, or low-level laser therapy even when exosomes are used.

• PRP: autologous and widely familiar
• mesotherapy: supportive and customizable
• exosomes: signal-focused, quality-dependent, not interchangeable with all other options

3. When it may make sense clinically

For hair, the best candidates are usually early to moderate thinning, post-transplant support, and patients who still have miniaturizing follicles. For lekure, the discussion is more about texture, recovery support, and gentle regenerative planning rather than dramatic lifting.

The weakest indication is complete overpromise. Exosome therapy does not replace surgery in bald scalp areas, does not automatically outperform PRP, and should not be sold as if every vial has the same quality standard.

• best in early biologically active stages
• product sourcing and regulation matter
• combination planning usually beats hype-driven monotherapy